Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine
- 1 June 1997
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 349 (9069) , 1877-1881
- https://doi.org/10.1016/s0140-6736(96)10168-9
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophyClinical Autonomic Research, 1996
- Some Specific Clinical Features Differentiate Multiple System Atrophy (Striatonigral Variety) From Parkinson's DiseaseArchives of Neurology, 1995
- Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopyAnnals of Neurology, 1995
- Unilateral Transplantation of Human Fetal Mesencephalic Tissue into the Caudate Nucleus of Patients with Parkinson's DiseaseNew England Journal of Medicine, 1992
- Growth hormone response to clonidine in central and peripheral primary autonomic failureThe Lancet, 1992
- Computed tomography, magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in multiple system atrophy and pure autonomic failureClinical Autonomic Research, 1991
- Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsyAnnals of Neurology, 1990
- The Value of Urethral Sphincter Electromyography in the Differential Diagnosis of ParkinsonismBritish Journal of Urology, 1989
- [27] Measurement of growth hormone-releasing factorPublished by Elsevier ,1986
- ParkinsonismNeurology, 1967